Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Acura Investors: Why Shares Popped 70%

As the Food and Drug Administration puts increasing amounts of pressure on pharmaceutical companies to release abuse-resistant varieties of their high-abuse-risk drugs, Acura (NASDAQ: ACUR  ) has done just that, and shares are soaring as a result. This is Acura's second abuse-resistant drug, but unlike Oxecta -- its version of oxycodone that is resistant to being crushed up and on which the company receives only milestones and royalties -- its new drug, Nexafed, which is an abuse-resistant form of Sudafed that prevents users from synthesizing methamphetamine from the drug, is wholly owned by Acura and should be even bigger for the company than Oxecta. The company is still down 30% from where it was at the beginning of 2012, but it is profitable and has no debt, which makes it an interesting company to keep an eye on.

See more in the following video.

While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2147520, ~/Articles/ArticleHandler.aspx, 10/26/2016 11:39:57 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,220.87 51.60 0.28%
S&P 500 2,143.78 0.62 0.03%
NASD 5,275.19 -8.21 -0.16%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/26/2016 11:22 AM
ACUR $1.11 Up +0.01 +0.70%
Acura Pharmaceutic… CAPS Rating: **
DRRX $1.17 Up +0.03 +2.62%
DURECT CAPS Rating: **
PFE $32.53 Up +0.25 +0.77%
Pfizer CAPS Rating: ****
PTIE $0.62 Down -0.02 -3.08%
Pain Therapeutics CAPS Rating: ***